“…Compounds 3,4,23,24,27,36,38, and 43 in Group I displayed highly potent antimalarial activity (IC 50 0.95-19.66 µM) and β-hematin formation inhibitory activity (IC 50 1.41-30.56 µM). In group II, compounds 11,13,16,17,20,34,37, 39, 44-50 showed potent antimalarial activity (IC 50 3.82-14.69 µM) but they possessed low β-hematin formation inhibition (less than 45% inhibition). On the other hand, compounds 25, 26, 28, and 42 in Group III were potent β-hematin formation inhibitor (IC 50 2.30, 2.54, 3.69, and 24.01 µM, respectively) but weak as antimalarial drug (less than 40% inhibition).…”